Alliance Pharma PLC Total Voting Rights (0746O)
08 June 2022 - 4:01PM
UK Regulatory
TIDMAPH
RNS Number : 0746O
Alliance Pharma PLC
08 June 2022
For immediate release 8 June 2022
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Total Voting Rights
Alliance Pharma plc (AIM: APH), the international healthcare
group, makes the following notification in accordance with the UK
Financial Conduct Authority's Disclosure and Transparency Rule
5.6.1.
As at 31 May 2022 the Company's issued share capital consists of
539,519,338 Ordinary Shares of 1p each.
The total number of voting rights in the Company is 539,519,338
and this figure may be used by shareholders as the denominator for
the calculations by which they should determine if they are
required to notify their interest in, or change to their interest
in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Cora McCallum, Head of Investor Relations
& Corporate Communications + 44 (0)1249 705168
ir@allianceph.com
+ 44 (0)20 7466
Buchanan 5000
Mark Court / Sophie Wills / Hannah Ratcliff
alliancepharma@buchanan.uk.com
+ 44 (0)20 7260
Numis Securities Limited 1000
Nominated Adviser: Freddie Barnfield / Duncan
Monteith
Corporate Broking: James Black
+ 44 (0)20 7597
Investec Bank plc 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare
group. Our purpose is to improve the lives of consumers and
patients through making available a range of clinically valuable
healthcare products.
Our core focus is on the marketing of Consumer Healthcare
brands, complemented by a smaller Prescription Medicines business.
In total, we hold marketing rights to around 80 brands, with
revenues generated from a mix of direct, distributor and e-commerce
sales.
Headquartered in the UK, Alliance employs around 250 people
based in locations across Europe, North America, and the Asia
Pacific region. By outsourcing our manufacturing and logistics
operations, we remain asset-light and focused on maximising the
value of our brands.
For more information on Alliance, please visit our website :
www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRUPUPUQUPPPGM
(END) Dow Jones Newswires
June 08, 2022 02:01 ET (06:01 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024